Phage Therapy As a Potential Solution in the Fight Against

Total Page:16

File Type:pdf, Size:1020Kb

Phage Therapy As a Potential Solution in the Fight Against ARTICLE https://doi.org/10.1057/s41599-020-0478-4 OPEN Phage therapy as a potential solution in the fight against AMR: obstacles and possible futures ✉ Charlotte Brives 1 & Jessica Pourraz2 ABSTRACT Phage therapy, the use of bacteriophage viruses to treat bacterial infections, has existed for more than a hundred years. However, the practice is struggling to develop, despite growing support over the past 15 years from researchers and doctors, who see it as a 1234567890():,; promising therapy in the context of the rise of antimicrobial resistance (AMR). While the reasons for these developmental difficulties are complex, in this article we wish to address the effects of pharmaceutical regulations on phage therapy. By showing how phages are assimilated to an umpteenth antibiotic in legal texts, but also in certain medical practices, this article proposes to analyze the consequences of such regulatory categorization both for their production and the logistics of administration of proof of their efficacy in randomized con- trolled trials (RCTs), as well as the underlying concepts of infection and treatment. This paper follows Chandler’s work on the concept of antibiotics as infrastructure and its inversion presented by antimicrobial resistance. Phages as living, dynamic, evolving, and specific entities, do not lend themselves easily to current categories, norms, and development models. In this sense, they act as disruptors, revealing the limitations imposed by the existing infrastructure. More precisely here, and to continue Chandler’s initial thought process, this paper aims to show that antibiotics also form a kind of epistemological infrastructure, which acts as a powerful inhibitor to the development of phage therapy. In this sense antibiotics prevent the development of solutions to the problem they contribute to create. But the difficulties phage therapy faces, as highlighted in this article, can be interpreted as entry points for thinking of another medicine and imagining other possible futures. This analysis is based on a 3-year fieldwork study (2016–2019) in Europe (France, Belgium, and Switzerland), during which we conducted semi-directed interviews with various phage therapy stake- holders (physicians, researchers, pharmacists, regulators, patients, and patient associations), participatory observation in labs and observations during symposia and workshops on phages and phage therapy. ✉ 1 CNRS, Bordeaux, France. 2 Faculté de Sociologie, Université de Bordeaux, Bordeaux, France. email: [email protected] PALGRAVE COMMUNICATIONS | (2020) 6:100 | https://doi.org/10.1057/s41599-020-0478-4 | www.nature.com/palcomms 1 ARTICLE PALGRAVE COMMUNICATIONS | https://doi.org/10.1057/s41599-020-0478-4 Introduction hage therapy, the use of bacteriophage viruses to treat the materiality of phages, evolving entities, imposes constraints bacterial infections, has existed for more than a hundred on both the respect of production norms imposed by regulations P ’ years (D Hérelle, 1931). However, the practice is struggling and the dominant model of drug development based on to develop, despite growing support over the past 15 years from scalability. researchers and doctors, who see it as a promising therapy in the After a brief review of the history of phage therapy and the context of the rise of antimicrobial resistance (AMR). While the mode of action of phages, we will describe the regulations in force reasons for these developmental difficulties are complex, in this in Europe, which classify bacteriophage viruses as medicinal article we wish to address the effects of pharmaceutical regula- products and their use, particularly in the French context. tions on phage therapy. For this we have adopted a theoretical By showing how phages are assimilated to an umpteenth approach from science and technology studies (STS) and philo- antibiotic in legal texts, but also in certain medical practices, we sophy of science. More precisely, we use the material-semiotic will analyze the consequences of such regulatory categorization method of the actor-network theory, and the principle of gen- for their production and for the administration of proof of their eralized symmetry that places humans and non-humans on the efficacy in randomized controlled trials (RCTs), as well as the same analytical plane (Callon, 1986; Latour, 2004). Our postulate underlying concepts of infection and treatment. is that we cannot understand the difficulties of phage therapy We will conclude with how some of the difficulties facing without taking into account both the socio-political context and phage therapy highlighted in this article can be interpreted as the very materiality of phages, their characteristics and entry points for imagining other possible futures. specificities. This analysis is informed by 3 years of fieldwork (2016–2019). Indeed, efforts to make phage therapy a viable and widely shared As one of us is a member of various scientific networks on phage practice must be analyzed within the framework of the AMR research and applications, and has trained in Biological Sciences, problem and the solutions proposed to deal with it (Podolsky, Anthropology of Science and Biomedical Sciences, she was able to 2018). More broadly, while the need to reduce antibiotic use by conduct participatory observations in laboratory contexts. We modulating individual behaviors is often highlighted (Broom et al., participated as observers in 10 symposia and workshops on 2015), it is the systemic and institutionalized dimension of anti- bacteriophages and phage therapy, during which we conducted biotics and their use that must be taken into account to understand intensive informal discussions with participants. We also con- how a new practice may or may not emerge. ducted 30 semi-directive and/or open interviews with scientists, The development of antibiotics, but above all of their modes of physicians, pharmacists, patients, start-up actors and regulatory production (Bud, 2009) and of mass-consumption, in both agency officers.1 As anthropologists, we are also part of a Ran- human and animal health (Hinchliffe et al., 2018; Kirchhelle, domized Controlled Trial, the aim of which is to assess the added 2018; Fortané, 2019), have had a profound and lasting impact on value of phages for bone infections. both human societies and bacteria, thus reminding us that the These different implications within the phage therapy field latter are not inert matter, but living organisms that act and react meant one of us could participate to a specialized committee on to their environment (Landecker, 2016). phage therapy at the French National Agency for the Safety of In a 2018 article, Chandler proposes to mobilize the notion of Medicines and Health Products (ANSM). From a strong inter- “infrastructure” as developed by Bowker and Star (1999), among disciplinary perspective, we also presented our work in work- others, as an analytical and programmatic framework to under- shops on phage therapy and in a Jacques Monod conference on stand the question of AMR: “Such infrastructure comprises viral evolution, generating added conversations and data about materials, information, ordering. For example, the availability and actors’ perspectives on the development of phage therapy. usability of research instruments and subjects shapes what science is constructed; the supply chain, techniques, and subject handling methods are invented alongside biology’s conceptual frame” A brief history of phage therapy (Chandler, 2018, p. 9). Chandler shows how “the present Not all viruses are pathogenic to humans. In fact, there is a awareness of antimicrobial resistance appears to have produced category of virus, bacteriophage viruses (or phages), which are an inversion whereby antimicrobials, and their attendant rela- hosted by bacteria. The human population will soon reach eight tions and processes, have come to the fore. This enables analyses billion, but the number of phages present in ecosystems is esti- of the possibilities, conventions, and constraints that have mated at more than 1031, making them the most represented hitherto been taken for granted as common sense, and the biological entity on Earth. These creatures, made up of protein or potential for reshaping these into the future” (Chandler, 2018). proteolipidic capsides containing fragments of nucleic acids (most This inversion of the infrastructure presented by AMR, and the often DNA, but also RNA), are present wherever bacteria can opportunity it offers to think of another medicine, seems to us to be be found. particularly highlighted by the case of phage therapy. Phages, living Humans have come to know and recognize them since the and dynamic, evolving and specific entities, do not lend themselves beginning of the 20th century. First mentioned in 1915 by Fre- easily to current categories, norms and development models. In this derick Twort (1915), they owe their therapeutic applications to sense, they are disruptors, revealing the limitations imposed by the Félix d’Hérelle, who isolated them in 1917 in the feces of con- existing infrastructure. More precisely here, rather than reinvesting valescing dysentery patients, while he was stationed at the Pasteur the various forms of the antibiotic infrastructure through the prism Institute in Paris (D’Hérelle, 1917). of phages, something that cannot be achieved in a single article, we Though the nature of the bacteriophages was a matter of dis- want to show that antibiotics also form a kind of epistemological pute only resolved
Recommended publications
  • Voluntarily Cooperation and the Celestial Twinning Bond
    Celestial Twins Voluntarily Cooperation and the Celestial Twinning Bond The Children’s Saviors: Emil Behring and Paul Ehrlich The Sign: Pisces Keyword: I believe Paul Ehrlich Emil Behring lthough today there is no precise definition of “twinning bond,” nobody denies its existence. This strong emotional or even telepathic bond is described in Aresearch of identical twins reared apart. The relationship between such twins is usually much more intense than that between unrelated people. They may share a closeness that would be hard to match in most other relationships, or they may compete with each other in a struggle to be first. Goering and Rosenberg seemed to belong to the latter category, their instinctive wish to be first dictated to them the desire to get rid of each other, yet even so, in the Nuremberg trials they did not blame each other. Was it just by chance that a kind of celestial twinning bond was observed in the previous stories, or is there a special system of relationships characteristic of celestial twins? Are celestial twins compelled to be in constant competition or do their joined efforts release unusually strong powers as are ascribed by mythology to some biological twins? Some of the answers to these intriguing questions I found in the comparative life stories of the Nobel Prize winners in Medicine, Emil von Behring and Paul Ehrlich. These celestial twins were, like Halem and Stauffenberg, born in Pisces. Though from birth separated by geography, religion and genes, they both found their life mission in Berlin, where both worked at the Institute of Hygiene.
    [Show full text]
  • Microbe Hunters Revisited Yale University School of Medicine, New Haven, Connecticut, USA
    INTERNATL MICROBIOL (1998) 1: 65-68 65 © Springer-Verlag Ibérica 1998 PERSPECTIVES William C. Summers Microbe Hunters revisited Yale University School of Medicine, New Haven, Connecticut, USA Correspondence to: William C. Summers. Yale University School of Medicine. 333 Cedar St. New Haven, CT 06520-8040. USA. Tel.: +1-203-785 2986. Fax: +1-203-785 6309. E-mail: [email protected] It was the mid-1950s and I was a teenager when I first Indeed, Microbe Hunters is a book about success: tales of read Microbe Hunters by Paul Henry De Kruif (Zealand, MI, brilliant research, incisive investigations, and heroic 1890–Holland, MI, 1971). It was the right time and the right personalities. Yet it is far from “history-objectively written.” age; I was fascinated. Here were heros enough to satisfy any The formula that De Kruif hit upon in Microbe Hunters served bookish young man interested in the natural world. Microbe him well: between 1928 and 1957 he wrote eleven more books Hunters was a book that inspired a generation or more of on medical and scientific topics, all with the same “exciting budding young microbiologists [4]. Not only that, however. narrative” and sense of drama. Some of these books were best- It established a metaphor and a genre of science writing that sellers and selected by the popular Book-of-the-Month Club. has often been imitated. None, however, matched the popularity and appeal of Microbe Microbe Hunters is a series of 12 stories that describe major Hunters. events in the history of microbiology, from microscopic De Kruif’s stories are full-scale dramatizations, complete observations of animalcules (literally “little animals”) by with fictional dialog of the historical subjects, and first person Leeuwenhoek (“First of the Microbe Hunters”) to Paul Ehrlich’s interjections of the voice of the narrator, De Kruif.
    [Show full text]
  • Nature Medicine Essay
    LASKER~KOSHLAND SPECIAL ACHIEVEMENT IN MEDICAL SCIENCE AWARD COMMENTARY I never met a microbe I didn’t like Stanley Falkow At the age of 11, I read Paul de Kruif’s Microbe Hunters, which dramatized the discovery of bacteria and viruses and their roles in human disease. The heroes of Microbe Hunters—Louis Pasteur, Robert Koch and others—became my heroes, and I dreamed of becoming a bacte- riologist, doing research on the bacteria that cause disease. I was lucky enough to fulfill my boyhood dream; however, I could never have imagined the path I eventually followed, or how much my views of microbes and disease would change (and continue to do so) in the process. Of course, I did not make this journey alone. During the five decades I worked as an active scientist, I helped train over 100 graduate Figure 1 Lab alumni reunion in 2004, Falkow/Tompkins home, Hamilton, Montana, USA. Photo students, postdoctoral fellows and clinical fel- courtesy of Manuel Amieva. lows, and collaborated with 75 other scientists (Fig. 1). Each of us, in our own way, wondered, Professor Herman Chase, a mouse geneticist, nicity. I was unable to transfer any gene from “What is a pathogen?” thought about my question and announced Salmonella or Shigella that altered the measur- that he had just the book to start me on my able pathogenicity or host range of another Entering the genetic and molecular world voyage, the just-published compilation The Salmonella species, or that made E. coli K-12 I was a hospital bacteriologist and an autopsy Chemical Basis of Heredity1.
    [Show full text]
  • Microbe Hunters Revisited •Fi Paul De Kruif and the Beginning of Popular
    The Texas Medical Center Library DigitalCommons@TMC John P. McGovern Historical Collections and Houston History of Medicine Lectures Research Center 3-7-2012 Microbe Hunters Revisited – Paul de Kruif and the Beginning of Popular Science Writing Stephen Greenberg Baylor College of Medicine Follow this and additional works at: https://digitalcommons.library.tmc.edu/homl Part of the History of Science, Technology, and Medicine Commons, and the Medicine and Health Sciences Commons Recommended Citation Citation Information:Greenberg, Stephen, "Microbe Hunters Revisited – Paul de Kruif and the Beginning of Popular Science Writing" (2012). DigitalCommons@TMC, John P. McGovern Historical Collections and Research Center, Houston History of Medicine Lectures. Paper 7. https://digitalcommons.library.tmc.edu/homl/7 This Article is brought to you for free and open access by the John P. McGovern Historical Collections and Research Center at DigitalCommons@TMC. It has been accepted for inclusion in Houston History of Medicine Lectures by an authorized administrator of DigitalCommons@TMC. For more information, please contact [email protected]. Houston History of Medicine Microbe Hunters Revisited March 7, 2011 Microbe Hunters Revisited – Paul de Kruif and the Beginning of Popular Science Writing Date: March 7, 2012 Speaker: Stephen Greenberg, M.D., Dean of Medical Education, Baylor College of Medicine Abstract: Paul de Kruif is credited with being one of the first popular science writers for the general public. He received his Ph.D. from the University of Michigan in 1916 and worked at the Rockefeller Institute under Simon Flexner. After being fired in 1922 for publishing a scathing article on medical research, de Kruif caught the attention of Sinclair Lewis, who used his scientific background to write his Pulitzer Prize winning novel, Arrowsmith.
    [Show full text]
  • Microbe Hunters 1St Edition Pdf, Epub, Ebook
    MICROBE HUNTERS 1ST EDITION PDF, EPUB, EBOOK Paul De Kruif | --- | --- | --- | 9780547542102 | --- | --- Microbe Hunters 1st edition PDF Book Email to friends Share on Facebook - opens in a new window or tab Share on Twitter - opens in a new window or tab Share on Pinterest - opens in a new window or tab. Longtime member. Chagas DiseaseA Kiss of Death. In the s, a boy called Louis Pasteur questioned why townsfolk died after a dog bite. Items must be sent back with our RMA number that we assign to each individual return — for our reference. Robinson as Ehrlich, with an Oscar-nominated script by John Huston. Published by Pocket 49, U. Eradication of Guinea Worm Disease. UlcersA Bacterial Infection. You are covered by the eBay Money Back Guarantee if you receive an item that is not as described in the listing. The most notable of these was Ross, the British scientist who received the Nobel Prize in Physiology or Medicine for identifying the role of the mosquito in malaria transmission. By this time in the early 20th century, the hygiene theory was widely accepted, and the germ theory had been well established, thus making the modern biomedical setting more recognizable to the reader. Paul De Kruif. Special financing available. Learn more. Rarely, if ever, have I been so disappointed in a book. Continual Permutations of Action Anselm L. With their original packaging and accessories included with the return. Menken, undertook freelance writing while continuing his teaching and laboratory research with Novy. Microbe Hunters is th biography of pioneers of medical research. If upon inspection your order contains a material fault or you received an incorrect item, please contact us before returning the item.
    [Show full text]
  • 2-Microbe-Hunters-Paul-De-Kruif.Pdf
    Microbe Hunters Paul de Kruif To RHEA A Harvest/HBJ Book Harcourt Brace Jovanovich, Publishers San Diego New York London Copyright 1926 by Paul de Kruif Copyright renewed 1954 by Paul de Kruif All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the publisher. Table of Contents 1. LEEUWENHOEK: First of the Microbe Hunters 2. SPALLANZANI: Microbes Must Have Parents! 3. PASTEUR: Microbes Are a Menace! 4. KOCH: The Death Fighter 5. PASTEUR: And the Mad Dog 6. ROUX AND BEHRING: Massacre the Guinea-Pigs 7. METCHNIKOFF: The Nice Phagocytes 8. THEOBALD SMITH: Ticks and Texas Fever 9. BRUCE: Trail of the Tsetse 10. ROSS VS. GRASSI: Malaria 11. WALTER REED: In the Interest of Science-and for Humanity! 12. PAUL EHRLICH: The Magic Bullet Footnotes Books by Paul de Kruif 1. LEEUWENHOEK: First of the Microbe Hunters 1 Two hundred and fifty years ago an obscure man named Leeuwenhoek looked for the first time into a mysterious new world peopled with a thousand different kinds of tiny beings, some ferocious and deadly, others friendly and useful, many of them more important to mankind than any continent or archipelago. Leeuwenhoek, unsung and scarce remembered, is now almost as unknown as his strange little animals and plants were at the time he discovered them. This is the story of Leeuwenhoek, the first of the microbe hunters. It is the tale of the bold and persistent and curious explorers and fighters of death who came after him.
    [Show full text]
  • Paul De Kruif, American Science Writer on Malaria: a Case Study
    Verhave MWJ 2011, 2:1 Paul de Kruif, American science writer on malaria: a case study Verhave, J.P. Honorary research fellow at the Van Raalte Institute, Hope College, Holland, Michigan [email protected] Abstract From 1926 onward, science writer Paul de Kruif has popularized the history of great discoveries in the science of diseases, malaria among them. During the thirties he focused on abuses and neglects of medical care and pointed to new developments, e.g., the treatment of syphilis with heat, rather than with malaria therapy. He conveyed his messages in popular magazines, using a romantic style and explicit language that was unheard of. He promoted new drugs, like Atabrine for endemic malaria and for the military engaged in (sub-) tropical war zones. Medical authorities were unhappy that his message about Atabrine was so dramatic, raising unwarranted hope of eradication. By the end of the Second World War, however, the usefulness of Atabrine was recognized. In my research I consulted original sources: letters, articles and books of De Kruif, as well as contemporary scientific publications; recent books on malaria history helped to design the historiography. Paul de Kruif’s dealing with various malaria topics is presented as a case study of science writing. Modern malaria research requires skilled journalists: they can excite public interest about problems in distant parts of the tropical world and work to raise funds. Journalists should also push for the translation of (bio-) medical progress to applicable tools in malaria control. 1 Introduction the state of health of the people. His book, Microbe Hunters (1926), became an overwhelming success and was trans- In 1847 a group of Dutch pioneers struggled in the forests lated into some twenty languages.
    [Show full text]
  • How American Comic Books Celebrated Heroes of Medicine in the 1940S
    148 bert hansen Medical History for the Masses: How American Comic Books Celebrated Heroes of Medicine in the 1940s BERT HANSEN summary: When comic books rose to mass popularity in the early 1940s, one segment of the industry specialized in “true adventures,” with stories about real people from the past and the present—in contrast to competing books that offered fantasy, science fiction, superheroes, detectives and crime, funny people, or funny animals. This study examines the figures from both medical history and twentieth-century medicine who were portrayed as heroes and role models in these comic books: first, to call attention to this very popular, if unknown, genre of medical history, and second, to illustrate how medical history was used at that time to popularize scientific and medical ideas, to celebrate the achievements of medical research, to encourage medical science as a career choice, and to show medicine as a humane and noble enterprise. The study explains how these medical history stories were situated in American popular culture more gener- ally, and how the graphic power of comic books successfully conveyed both values and information while also telling a good story. Attention to this colorful genre of popular medical history enriches our picture of the mid-twentieth- century public’s enthusiasm for medical progress. keywords: cartoons, comic books, medical history, medical heroes, popular culture, Golden Age, scientific method, medical research Presentations of this research were made at the 73rd Annual Meeting of the American Association for the History of Medicine, Bethesda, Md., on 21 May 2000, and at Queens University, Kingston, Ont., on 10 October 2000.
    [Show full text]
  • Curriculum Vitae Paul Ehrlich (*1854 - †1915) German Medical Doctor – Serology and Immunology
    Curriculum Vitae Paul Ehrlich (*1854 - †1915) German medical doctor – serology and immunology 1915 Paul Ehrlich died after a serious illness on 20 August 1915 at Bad Homburg vor der Höhe, Germany- 1912 Honorary citizen of Frankfurt a.M. and his birthplace, Strehlen, Germany 1911 Appointed as “Real Privy Councillor” with the additional title of “Excellency” (the highest civilian honour of the Prussian state) 1909 Discovery of Salvarsan (also called: Dioxy-diamino-arsenobenzol-dihydrochloride or preparation "606“), the first preparation for the treatment of syphilis, in co-operation with his most important co-worker, Sahachiro Hata 1908 Received the Nobel Prize for “Immortal contribution to medical and biological research, particularly to the valency determination of sera preparations”, together with Elia Metschnikow, who discovered phagocytosis 1907 Appointed as privy senior officer of health, honorary doctorate at Oxford 1906 Head of the Georg-Speyer-House for Chemotherapy 1904 Full Honorary Professor of the University of Göttingen and honorary doctorate of the University of Chicago 1903 Award winner of the Great Golden Medal of Science 1899 Head of the “Royal Institute of Experimental Therapy” at Frankfurt am Main 1897 Appointed as Privy Medical Officer of Health Publication of his side-chain theory in an essay “On the determination of the valency of the diphtheria serum” 1896 Appointed as Head of the “Institute for Sera Research and Serum Testing” that had been newly established in Steglitz, near Berlin 1891 Appointed by Robert Koch to the newly established Institute of Infectious Diseases in Berlin (today: Robert Koch Institute). There, he worked on the extraction of diphtheria serum and the determination of its concentration and valency and developed an internationally acknowledged unit of measurement.
    [Show full text]
  • Clifford Dobell and the Making of Paul De Kruif's Microbe Hunters
    Medical History, 2010, 54: 529–536 Clifford Dobell and the Making of CORE Metadata, citation and similar papers at core.ac.uk Provided by PubMed Central Paul de Kruif’s Microbe Hunters JAN PETER VERHAVE* While researching the activities of Paul de Kruif, an American microbiologist and medical science journalist,1 I came across some previously unknown correspondence of interest for the history of malaria research and of the history of medicine generally. It sheds new light on the origin of De Kruif’s book Microbe hunters and more particularly on his description of the discovery of the transmission of malaria parasites by mosquitoes. The letters were written by Clifford Dobell, a British protozoologist, to his friend Paul de Kruif.2 They triggered a little-known sequel to the priority battle between the two discoverers of the transmission of malaria parasites, Ronald Ross and Giovanni Battista Grassi. Colleagues and Friends Before earning his living from writing, Paul de Kruif (1890–1971) had carried out front- line bacteriological research at Michigan University, as a US medical corps officer during the First World War in France, and thereafter at the Rockefeller Institute, New York. He chose, however, to become a writer and, specifically, a science journalist. One of the reasons was his dissatisfaction with the unscientific and arrogant attitude of the American medical profession in general. It resulted in a rather critical book Our medicine men (1922) that cost him his position as a researcher. The next episode in his career was the collaboration with Sinclair Lewis on Arrowsmith (1925), a medical novel.
    [Show full text]
  • Twentieth Century: Arro Wsmith and the Doctor's Dilemma
    Medical History, 1988, 32: 314-332. IMMUNOLOGY AND LITERATURE IN THE EARLY TWENTIETH CENTURY: ARRO WSMITH AND THE DOCTOR'S DILEMMA by ILANA LOWY* Scientific research is at the centre of two important literary works published in the early twentieth century: George Bernard Shaw's play The doctor's dilemma (1906), and Sinclair Lewis's novel, Arrowsmith (1925). Both deal with medical science, and in both the hero is an immunologist (or, in the terminology of the period, a specialist in the science of immunity). But the images of immunology in Shaw's play and in Lewis's book are very different. Moreover, the same real-life scientist, the flamboyant Sir Almroth Wright and the same immunological theory, Wright's opsonin theory, appear in both works, but in diametrically opposed roles. Wright is the barely disguised prototype of Shaw's hero, the scientist Sir Colenso Ridgeon, and Shaw represents the opsonin theory as the most advanced form ofscientific knowledge. The name ofWright is seldom mentioned explicitly in Arrowsmith but his opsonin theory is the incarnation ofthe false theories ofimmunity fought by Max Gottlieb, the exemplary scientist in the novel. Whywas the young science ofimmunology honoured by placementat thecentre oftwo major literary works? Why was the study ofimmunity the right occupation for a literary hero in the early twentieth century? And what is the basis ofthe differences in Shaw's and Lewis's presentations of this discipline, differences made explicit by their opposed evaluations ofthe same scientist and the same theory?Answering these questions can help us not only to obtain some new insights into these literary works, but also to understand the evolution ofimmunology in the context ofthe rapid but by no means unproblematic penetration of scientific ideas into early twentieth-century medicine.
    [Show full text]
  • Early History of Microbiology and Microbiological Methods
    1 EARLY HISTORY OF MICROBIOLOGY AND MICROBIOLOGICAL METHODS Robert F. Guardino AAI Development Services Wilmington, N.C. USA INTRODUCTION The original title of this chapter was to be “History of Microbiological Methods.” This would seem to indicate that inquisitive minds were consciously attempting to develop new methods for a new field of science. Or perhaps they had a “for profit” motive as if they were working for a company driving them towards new markets or to increase their portfolio of patents from which to draw royalties. This could not be further from the truth. Rather, the history of microbiology is a story of some common folk and other rather peculiar individuals, janitors and hobbyists, amateur lens grinders and chemists, physicians and botanists, housewives and laboratory “slaves” with a quest for discovery. These explorers were sometimes driven by chance or curiosity, and sometimes by a problem for which no one had an answer. And, they were driven sometimes by pride or self-interest. But then there were those altruistic ones driven by the pure compassion for suffering humanity. With the topic being rather broad, and the space being somewhat limited, the scope had to be narrowed so this chapter has mutated into one that attempts to expose the minds behind the discoveries; 1 www.pda.org/bookstore 2 Encyclopedia of Rapid Microbiological Methods discoveries that necessitated the rather simple, though not always obvious, techniques that made revealing the world of microorganisms possible. The story that unfolds is first a history of events and phenomenon for which there was no understanding or explanation, followed by observations for which there was no obvious application, to the eventual association of cause and effect, on to a full blown field of inquiry.
    [Show full text]